Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Intangibles (2020 - 2025)

Agilon Health (AGL) has disclosed Intangibles for 6 consecutive years, with $65.6 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Intangibles changed N/A year-over-year to $65.6 million, compared with a TTM value of $65.6 million through Jun 2025, changed N/A, and an annual FY2024 reading of $72.8 million, up 14.12% over the prior year.
  • Intangibles was $65.6 million for Q2 2025 at Agilon Health, down from $72.8 million in the prior quarter.
  • Across five years, Intangibles topped out at $130.8 million in Q4 2022 and bottomed at $53.7 million in Q1 2022.
  • Average Intangibles over 5 years is $81.4 million, with a median of $72.1 million recorded in 2024.
  • Peak annual rise in Intangibles hit 50.68% in 2023, while the deepest fall reached 51.25% in 2023.
  • Year by year, Intangibles stood at $108.7 million in 2021, then increased by 20.33% to $130.8 million in 2022, then plummeted by 51.25% to $63.8 million in 2023, then grew by 14.12% to $72.8 million in 2024, then fell by 9.86% to $65.6 million in 2025.
  • Business Quant data shows Intangibles for AGL at $65.6 million in Q2 2025, $72.8 million in Q4 2024, and $72.1 million in Q1 2024.